Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Patriarca

Showing results (21-30 of 156) with videos related to

Pageof 16
Sort By:
Haematologica|February 12, 2002
B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopeniaFrancesco Zaja, Isabella Iacona, Paola Masolini, et al.
Experimental Hematology|March 18, 2006
The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recoveryFrancesca Patriarca, Cristina Skert, Alessandra Sperotto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 17, 2017
Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous TransplantationFrancesca Patriarca, Benedetto Bruno, Hermann Einsele, et al.
European Journal of Haematology|March 3, 2010
Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarinMichela Cini, Elena Zamagni, Lelia Valdré, et al.
Experimental Hematology|February 5, 2017
Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemiaAnna Candoni, Federico De Marchi, Francesca Zanini, et al.
Haematologica|September 8, 2006
Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantationFrancesca Patriarca, Cristina Skert, Francesca Bonifazi, et al.
The Oncologist|February 12, 2015
Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centersCarmelo Carlo-Stella, Francesca Ricci, Serena Dalto, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 12, 2023
Stem Cells mobilization and collection in allogeneic related and unrelated donors: a single center experience with focus on plerixaforChiara Marcon, Antonella Bertone, Sara Mauro, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2025
Immune Effector Cell-Associated Neurotoxicity Delayed Relapse After Chimeric Antigen Receptor T-Cell Therapy: A Case ReportAnna Favero, Sara Mohamed, Marta Lisa Battista, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2012
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantationVittorio Montefusco, Francesco Spina, Francesca Patriarca, et al.
Pageof 16

Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
Haematologica|February 12, 2002
B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopeniaFrancesco Zaja, Isabella Iacona, Paola Masolini, et al.
Experimental Hematology|March 18, 2006
The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recoveryFrancesca Patriarca, Cristina Skert, Alessandra Sperotto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 17, 2017
Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous TransplantationFrancesca Patriarca, Benedetto Bruno, Hermann Einsele, et al.
European Journal of Haematology|March 3, 2010
Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarinMichela Cini, Elena Zamagni, Lelia Valdré, et al.
Experimental Hematology|February 5, 2017
Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemiaAnna Candoni, Federico De Marchi, Francesca Zanini, et al.
Haematologica|September 8, 2006
Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantationFrancesca Patriarca, Cristina Skert, Francesca Bonifazi, et al.
The Oncologist|February 12, 2015
Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centersCarmelo Carlo-Stella, Francesca Ricci, Serena Dalto, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 12, 2023
Stem Cells mobilization and collection in allogeneic related and unrelated donors: a single center experience with focus on plerixaforChiara Marcon, Antonella Bertone, Sara Mauro, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2025
Immune Effector Cell-Associated Neurotoxicity Delayed Relapse After Chimeric Antigen Receptor T-Cell Therapy: A Case ReportAnna Favero, Sara Mohamed, Marta Lisa Battista, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2012
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantationVittorio Montefusco, Francesco Spina, Francesca Patriarca, et al.
Pageof 16